将Gba1的E326K突变与微质激活和轻微的依赖年龄的多巴胺基神经退行症联系起来
bioRxiv : the preprint server for biology
|September 25, 2023
概括
GBA1基因的突变与帕金森病 (PD) 有关. 这项研究表明,GBA1缺乏导致神经炎症和α-synuclein积累,恶化PD症状.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 遗传学 是一个
- 病理学 病理学 病理学
背景情况:
- 葡萄糖大脑酶1 (GBA1) 基因的突变是帕金森病 (PD) 的一个主要遗传风险因素.
- 缺乏GBA1导致溶酶体功能障碍和α-syn核素 (α-syn) 积累.
- 新出现的证据表明,神经炎症与GBA1缺乏相关的PD病原发生有关.
研究的目的:
- 研究GBA1缺乏导致神经炎症的分子机制.
- 探索GBA1 E326K突变在PD和勒维体痴呆症 (DLB) 中的作用.
主要方法:
- 使用CRISPR/Cas9.9生成了GBA1 E326K敲进 (KI) 鼠标模型.
- 在老年KI小鼠中评估了GBA1酶活性,葡萄糖胺水平和微质密度.
- 从KI小鼠培养了原发性微质细胞和星体细胞,并用α-synuclein预制纤维素 (PFF) 处理它们.
- 给KI小鼠服用肠道α-syn PFF,以评估Lewy体积累和症状进展.
主要成果:
- GBA1 E326K KI小鼠表现出GBA1活性降低,葡萄糖胺含量增加和微质密度升高.
- 在暴露于α-syn PFF的培养细胞中,促炎性细胞因子和反应性星球细胞增加.
- 在KI小鼠中,肠道α-syn PFF注射使Lewy体病理,神经炎症和非运动症状恶化.
结论:
- 缺乏GBA1促进α-synuclein介导的神经炎症和细胞间传播.
- GBA1 E326K突变通过炎症途径加剧了PD和DLB病理.
- 这些发现突出了GBA1相关的神经退行性疾病的潜在治疗点.
更多相关视频
10:40Immunofluorescence Staining Using IBA1 and TMEM119 for Microglial Density, Morphology and Peripheral Myeloid Cell Infiltration Analysis in Mouse Brain
Published on: October 27, 2019
32.3K
07:46Gait Analysis of Age-dependent Motor Impairments in Mice with Neurodegeneration
Published on: June 18, 2018
12.0K
相关概念视频
Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
